Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia

Clinical trial NCT01358253 · COMPLETED

Trial details

NCT number: NCT01358253
Sponsor: Ruijin Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2010-12-01
Primary completion: 2012-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.